Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity
Press release – No. 17 / 2026 Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity The Phase 3 initiation marks a defining step toward establishing…
India's Top 10 Pharma Companies Sustain Volume Growth, Outperforming Smaller Rivals
India's leading pharmaceutical companies are consistently outperforming their smaller counterparts in volume growth, driven by strategic advantages and a significant market shift towards high-value chronic and sub-chronic therapies. India's top 10…
Ascendis Pharma (NASDAQ: ASND) Severs Novo Nordisk Tie To Take Full Control Of TransCon Metabolic Pipeline
Ascendis Pharma (NASDAQ: ASND) has reclaimed exclusive rights to its TransCon technology-based products across metabolic and cardiovascular diseases following the termination of its collaboration with Novo Nordisk (NYSE: NVO). The move signals a…
Fredun Pharma acquires 26% stake in Goodman Vetcare Private Limited
Fredun Pharmaceuticals Limited has acquired a 26 percent stake in Goodman Vetcare Private Limited, for an undisclosed sum. This is Fredun Pharma's second acquisition in the animal health and veterinary retail and pet-care market, in less than two…
Pharmalittle: We're reading about pharma seeking to protect China deals, a Roche obesity drug, and more
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every new day should be…
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Cybin NASDAQ: HELP, doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to…
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts (LH)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
European drugmakers say they are 'losing ground' to US and Chinese rivals
Some of Europe's biggest pharmaceutical companies have said the continent is “losing ground” to rivals including the US and China in developing new drugs and attracting investment. The chairs of nine companies, including Britain's…
Sensex, Nifty Pare Early Gains Despite Global Markets' Rally, Easing Crude Prices
Indian benchmark indices Sensex and Nifty opened higher on global market rally and easing crude oil prices but pared gains and are trading in red. Indian benchmark indices Sensex and Nifty recorded gains in early trade, continuing their upward…
Sensex Nifty Drop: IT, Financials Drag Indian Equities Amid Global Optimism
Indian benchmark indices, Sensex and Nifty, experienced a notable decline on Tuesday, primarily driven by underperformance in key sectors like IT and financials, even as global markets showed positive trends and crude oil prices eased. The BSE…
Midterms' new populism: Taking on health industries
The willingness to confront powerful health care interests is becoming a litmus test for candidates in congressional battleground races with six weeks to go before the midterm elections. Why it matters: Forget the old Affordable Care Act wars.
Sensex drops 330 points, Nifty down to 23,329 dragged by IT stocks
Benchmark indices Sensex and Nifty ended lower on Tuesday despite a positive trend in global markets and easing crude oil prices, dragged by IT, financials and capital goods stocks. The 30-share BSE Sensex declined 329.91 points, or 0.44 per cent…
This security technology stock has an 'underappreciated' edge, Jefferies says
Crane NXT 's advantages in security technology seem 'underappreciated' by investors, making now a good time to scoop up shares, according to Jefferies. The investment firm initiated coverage of the security tech stock with a buy rating. It also put…
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
Dividend stocks are always great additions to a portfolio, as they offer investors the opportunity to earn passive income during any economic or market environment. This may compensate for weakness in your portfolio during tough market times and…
Novo CEO signals M&A opportunities to strengthen drug pipeline
Novo CEO Mike Doustdar told CNBC the company was mulling M&A opportunities amid increasing competition. He was speaking the day after the Danish pharma giant's stock fell nearly 8%, after a turnaround plan failed to placate investors. Michael Nagle…
Receive a Daily briefing on Pharma Industry News
Get Started